AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MEDICA GROUP PLC

Director's Dealing Nov 8, 2022

4972_dirs_2022-11-08_7594b1ba-2a36-4b8f-9012-7829288dd65e.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7148F

Medica Group PLC

08 November 2022

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (the "Company") announces that on 7 November 2022, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Deferred Bonus Plan 2017 at a nil exercise price:

Name of PDMR Number of shares subject to option
Stuart Quin 87,409
Richard Jones 61,700
Kevin Terrins 38,181
Sarah Burns 38,181
Marc O'Brien

Caroline Byrne

Rob Lavis
46,275

21,389

24,722

The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation, and set out more details of the transactions.

1. Details of PDMR
(a) Name 1.           Stuart Quin

2.           Richard Jones

3.           Kevin Terrins

4.           Sarah Burns

5.           Marc O'Brien

6.           Caroline Byrne

7.           Rob Lavis
2. Reason for notification
(b) Position / status 1.           Chief Executive Officer

2.           Chief Financial Officer

3.           Group Director of Corporate Development

4.           Managing Director, UK

5.           Chief Information Officer

6.           Managing Director, Ireland

7.           Group Medical Director
Initial notification / amendment Initial notification in each case
3. Details of the Issuer
(a) Name Medica Group PLC
(b) LEI 213800B8XE5FUSZF5Z16
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted
(a) Description of the financial instrument Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b) Nature of the transaction Grant of options to acquire Shares pursuant to the Company's Deferred Bonus Plan 2017
(c) Price(s) and volume Option Price nil in each case

1.          87,409

2.          61,700

3.          38,181

4.          38,181

5.          46,275

6.          21,389

7.          24,722
(d) Aggregated information N/A
(e) Date of the transaction 7 November 2022
(f) Place of the transaction Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBKFBBNBDDDDK

Talk to a Data Expert

Have a question? We'll get back to you promptly.